GlassScriptPhysician profile
Maryjane Scoco
NPI 1083862627
$1,616.67
in general payments reported to CMS, 2019-2025
25 companies · $98.56 in 2025
The $98.56 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $243 · 2022: $627 · 2023: $305 · 2024: $343 · 2025: $98.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $747.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $747.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $168.85 | 2021-2024 | Mounjaro |
| Astellas Pharma US INC | $125.49 | 2022-2023 | Myrbetriq, Veozah |
| Biohaven Pharmaceutical Holding Company LTD. | $115.79 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $112.07 | 2021-2024 | Austedo Xr |
| Abbott Laboratories | $105.97 | 2021-2023 | Freestyle Libre 3, Freestyle Libre 2 |
| Novartis Pharmaceuticals Corporation | $103.25 | 2022-2023 | |
| Otsuka America Pharmaceutical, INC. | $99.64 | 2022-2024 | Rexulti, Abilify Maintena |
| Calliditas Therapeutics US INC. | $98.56 | 2025 | Tarpeyo |
| Novo Nordisk INC | $84.91 | 2021-2024 | Ozempic, Rybelsus |
| Impulse Dynamics (USA) INC. | $79.27 | 2024 | Optimizer |
| Astrazeneca Pharmaceuticals LP | $70.15 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $58.41 | 2021-2022 | |
| Glaxosmithkline, LLC. | $54.93 | 2022-2023 | Trelegy Ellipta |
| Amgen INC. | $51.46 | 2021-2023 | Repatha, Otezla |
| Abbvie INC. | $50.87 | 2022-2023 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.79 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $30.40 | 2021 | |
| Daiichi Sankyo INC. | $25.88 | 2022 | |
| Lundbeck LLC | $24.43 | 2023 | Rexulti |
| Nestle Healthcare Nutrition INC. | $23.42 | 2021 | |
| Amarin Pharma, INC. | $22.22 | 2021 | |
| Jazz Pharmaceuticals INC. | $20.98 | 2022 | |
| Merck Sharp & Dohme LLC | $20.53 | 2023 | Verquvo, Belsomra |
| Exact Sciences Corporation | $17.22 | 2023 | Cologuard Collection Kit |
| Exeltis, USA INC. | $14.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maryjane Scoco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.